Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 12086-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#12086-1-AP, RRID:AB_10859816
- Product name
- SLC25A10 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated SLC25A10 antibody (Cat. #12086-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Mitochondrial transport of glutathione in diabetic retinopathy.
Mitochondrial SLC25A10 promotes prostate cancer progression by inhibiting ferritinophagy.
Silybin inhibits succinate production and secretion in hepatocytes to reverse liver fibrosis.
Inhibition of SLC25A10 promotes cellular senescence and impedes hepatocellular carcinoma progression.
MPV17 Prevents Myocardial Ferroptosis and Ischemic Cardiac Injury through Maintaining SLC25A10-Mediated Mitochondrial Glutathione Import.
Mild Therapeutic Hypothermia Alleviated Myocardial Ischemia/Reperfusion Injury via Targeting SLC25A10 to Suppress Mitochondrial Apoptosis.
The role of PYCR1 in inhibiting 5-fluorouracil-induced ferroptosis and apoptosis through SLC25A10 in colorectal cancer.
SLC25A10 performs an oncogenic role in human osteosarcoma.
Kowluru RA, Malaviya P
Free radical biology & medicine 2025 Sep;237:357-368
Free radical biology & medicine 2025 Sep;237:357-368
Mitochondrial SLC25A10 promotes prostate cancer progression by inhibiting ferritinophagy.
Yu G, Chen K, Xu B, Cao Q
Cell death discovery 2025 May 20;11(1):242
Cell death discovery 2025 May 20;11(1):242
Silybin inhibits succinate production and secretion in hepatocytes to reverse liver fibrosis.
Yang X, Lou Y, Li H, Ma Y, Wang Z, Aa J, Wang G, Xie Y
Archives of pharmacal research 2025 Aug;48(7-8):782-797
Archives of pharmacal research 2025 Aug;48(7-8):782-797
Inhibition of SLC25A10 promotes cellular senescence and impedes hepatocellular carcinoma progression.
Ding YH, Huang TY, Xu SM, Li M, Shi X, Sun WY, Lu CH, Liu ZX, Huang W
Translational cancer research 2025 Aug 31;14(8):4939-4954
Translational cancer research 2025 Aug 31;14(8):4939-4954
MPV17 Prevents Myocardial Ferroptosis and Ischemic Cardiac Injury through Maintaining SLC25A10-Mediated Mitochondrial Glutathione Import.
Xu T, Chen G
International journal of molecular sciences 2024 Oct 9;25(19)
International journal of molecular sciences 2024 Oct 9;25(19)
Mild Therapeutic Hypothermia Alleviated Myocardial Ischemia/Reperfusion Injury via Targeting SLC25A10 to Suppress Mitochondrial Apoptosis.
Ma S, Song Y, Xu Y, Wang C, Yang Y, Zheng Y, Lu Q, Chen Q, Wu J, Wang B, Chen M
Journal of cardiovascular translational research 2024 Aug;17(4):946-958
Journal of cardiovascular translational research 2024 Aug;17(4):946-958
The role of PYCR1 in inhibiting 5-fluorouracil-induced ferroptosis and apoptosis through SLC25A10 in colorectal cancer.
Zhou B, Mai Z, Ye Y, Song Y, Zhang M, Yang X, Xia W, Qiu X
Human cell 2022 Nov;35(6):1900-1911
Human cell 2022 Nov;35(6):1900-1911
SLC25A10 performs an oncogenic role in human osteosarcoma.
Wang G, Xia J, Chen C, Qiu J, Sun P, Peng Z, Chen X, Xu B
Oncology letters 2020 Oct;20(4):2
Oncology letters 2020 Oct;20(4):2
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The SLC25A10 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human SLC25A10. This antibody recognizes human, mouse, rat antigen. The SLC25A10 antibody has been validated for the following applications: ELISA, WB analysis.
